Skip to main content
2025 AABB Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Event Icons
Assessor Sessions
Assessor Sessions
Committee Meetings
Committee Meetings
Foundation Events
Foundation Events
Networking Events
Networking Events
Oral Abstracts
Oral Abstracts
CABP Eligible
CABP Eligible
Video Recording

Cord Blood

CBC: The Role of MSC´s in the Development of Regenerative Cell Therapies

AM25-ST-23-L - CBC: The New Frontiers of MSC´s in Regenerative Medicine

Saturday, October 25, 2025
8:15 AM - 9:15 AM  PT
Room: SDCC 32
CE: 0 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
CABP Eligible

    Program Chair(s)

  • Joanne Kurtzberg, MD

    Jerome Harris Distinguished Professor of Pediatrics Professor of Pathology Director, Marcus Center for Cellular Cures Director, Carolinas Cord Blood Bank Co-Director, Stem Cell Transplant Laboratory President, Cord Blood Association
    Duke University
    Durham, North Carolina

    Disclosure(s): Celularity: Consultant/Advisory Board (Ongoing); CryoCell International: Full-time/Part-time Employee or Owner (Ongoing); HemxBio: Consultant/Advisory Board (Ongoing); Mesoblast: Consultant/Advisory Board (Ongoing); Supercell (formally Sinocell): Duke license with Sinocell, received royalties (Ongoing)

    Handouts

    • Speaker(s)

  • EA

    Ed Ahn, Ph.D (he/him/his)

    Chief Executive Officer & Director
    MEDIPOST, Inc.
    Cambridge, Massachusetts

    Disclosure(s): No financial relationships to disclose

    Handouts

  • Shibani Pati, MD PhD (she/her/hers)

    Professor and Vice Chair of Research Dept. of Lab Medicine
    University of California San Francisco
    Woodside, California

    Disclosure(s): No financial relationships to disclose

    Handouts

  • Peter McSweeney, MB, ChB (he/him/his)

    Head of Medical Affairs
    Mesoblast
    New York, New York

    Disclosure(s): Mesoblast Inc: Full-time/Part-time Employee or Owner (Ongoing)

    Handouts
How can MSC´s, in particular cord tissue derived MSC´s, expand the scope of our sector evolving from a cord blood transplantation focus to a broader cell therapy approach, in other specialties such as pediatrics, endocrinology, neurology, among others.

Learning Objectives:

  • Where do we stand in regenerative cell therapies using MSC's
  • Cord blood-derived MSC's to treat cartilage degeneration
  • Bone Marrow MSC's to reat acute GVHD